Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C John Clements

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Vaccine|May 4, 2004
The evidence for the safety of thiomersal in newborn and infant vaccinesC John Clements
Drug Safety|June 20, 2003
Mass psychogenic illness after vaccinationC John Clements
The Indian Journal of Medical Research|August 24, 2006
Vaccine preservatives: what is the big deal?C John Clements
Australian and New Zealand Journal of Public Health|August 30, 2007
Gardasil and mass psychogenic illnessC John Clements
Vaccine|August 3, 2010
Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa--too soon?Anna Kramvis, C John Clements
Expert Review of Vaccines|July 20, 2005
Vaccine presentations and delivery technologies--what does the future hold?C John Clements, Steve L Wesselingh
Australian and New Zealand Journal of Public Health|December 22, 2005
Feeling bad about immunising childrenAbigail L Wroe, C John Clements
Expert Opinion on Drug Safety|December 24, 2005
When science is not enough - a risk/benefit profile of thiomersal-containing vaccinesC John Clements, Peter B McIntyre
Journal of Health, Population, and Nutrition|March 3, 2009
Measuring progress towards millennium development goals by province in populous countriesAshley J Clements, C John Clements
Vaccine|May 4, 2004
Technologies that make administration of vaccines saferC John Clements, Gordon Larsen, Luis Jodar
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Vaccine|May 4, 2004
The evidence for the safety of thiomersal in newborn and infant vaccinesC John Clements
Drug Safety|June 20, 2003
Mass psychogenic illness after vaccinationC John Clements
The Indian Journal of Medical Research|August 24, 2006
Vaccine preservatives: what is the big deal?C John Clements
Australian and New Zealand Journal of Public Health|August 30, 2007
Gardasil and mass psychogenic illnessC John Clements
Vaccine|August 3, 2010
Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa--too soon?Anna Kramvis, C John Clements
Expert Review of Vaccines|July 20, 2005
Vaccine presentations and delivery technologies--what does the future hold?C John Clements, Steve L Wesselingh
Australian and New Zealand Journal of Public Health|December 22, 2005
Feeling bad about immunising childrenAbigail L Wroe, C John Clements
Expert Opinion on Drug Safety|December 24, 2005
When science is not enough - a risk/benefit profile of thiomersal-containing vaccinesC John Clements, Peter B McIntyre
Journal of Health, Population, and Nutrition|March 3, 2009
Measuring progress towards millennium development goals by province in populous countriesAshley J Clements, C John Clements
Vaccine|May 4, 2004
Technologies that make administration of vaccines saferC John Clements, Gordon Larsen, Luis Jodar
Pageof 3